Skip to content

MEDISOINS BRUXELLES

Active Private limited companyfounded 2008active for 17 yearsGeurstraat 9, 1070 AnderlechtKBO/BCE: BE 0809.009.197

Lifetime

15 annual accounts with figures on one time axis
peak of €236,653 in 2014
€65,201▲ 153%
lowest -€36,300 in 2019
€21,732▲ €24,688
peak of €208,233 in 2022
€177,415▼ 7.0%
€86,011▲ 69.6%
peak of 5 FTE in 2013
-not published
Board2 names since 2020
1 director
Documentsfilings and deeds
26-06-202635 days before the deadline
2025micro format
Gross margin from €25,775 to €65,201Profit of €21,732, after a lossDividend €35,000Debts from €50,712 to €86,011Cash from €63,533 to €111,844

Key points

from the 2025 annual accounts

Equity

€177,415 ▼ 7.0%
190,6832024+21,732Profit-35,000Dividend177,4152025

MEDISOINS BRUXELLES paid out €35,000 in dividends. That is 161% of the 2025 profit.

Turnover

≈ €190,000 estimated

The accounts state no turnover.

Filings

15 annual accounts since 2009
AprilJune31 JulyOctober2010201520202025

Seven of the last ten came late. The 2018 accounts came in latest, 229 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 34,726 companies had the same profile as MEDISOINS BRUXELLES has now. Each dot stands for 87 companies, two years later.

95.2%
were still trading
4.0%
stopped another way
0.7%
went bankrupt
  • Micro
  • 10 to 20 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more
Test of the method

The method was tested on the 497,965 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 34,726 companies, not a prediction for MEDISOINS BRUXELLES. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
  • deed of 17-02-2020
Board & ownership

Recent changes

reappointed as director 186 shares · General meeting of 04-12-2023 · Gazette deed
resigns as manager Transfer of shares from to · General meeting of 31-12-2019 · Gazette deed
Registered office moved within Brussels The registered office moved from Rue d'Aumale 16 1070 Bruxelles to Rue des Parfums n° 9, 1070 Bruxelles · General meeting of 20-11-2014 · Gazette deed
First establishment Geurstraat 9, Anderlecht
All 32 events

Official details

Source: KBO
Status
Active since 30-12-2008Normal situation
Activity
“1) Aide aux personnes : (entre autres: aides ménagères — aides familiales et autres)…” (deed in French)From the articles, 8 activities6 activities on the establishment unit
Establishment unit
2.176.525.1941070 Anderlecht, since 02-03-2009
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

€263,426▲ 9.1%
Filing
Filed on 26-06-2026, 35 days before the end of the filing period
Financials

Insights on MEDISOINS BRUXELLES

MEDISOINS BRUXELLES files the micro format. That format states no turnover. The gross margin rose from €27,713 in 2009 to €65,201 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about MEDISOINS BRUXELLES

What is the company number of MEDISOINS BRUXELLES?
The company number of MEDISOINS BRUXELLES is 0809.009.197. The VAT number is the same number with BE in front: BE 0809.009.197.
Where is MEDISOINS BRUXELLES based?
The registered office is at Geurstraat 9, 1070 Anderlecht.Company details
What is the legal form of MEDISOINS BRUXELLES?
MEDISOINS BRUXELLES is a private limited company (BV).
When was MEDISOINS BRUXELLES founded?
MEDISOINS BRUXELLES was founded on 30-12-2008.
Is MEDISOINS BRUXELLES still active?
Yes, MEDISOINS BRUXELLES is an active enterprise in the KBO register.
How many employees does MEDISOINS BRUXELLES have?
MEDISOINS BRUXELLES had an average of 1 full-time equivalents in financial year 2022, according to the filed annual accounts.Financials
What is the turnover of MEDISOINS BRUXELLES?
The turnover in financial year 2025 is ≈ €190,000. This figure is estimated from the gross margin of €65,201 and 2,981 comparable companies of the same size. It probably lies between €130,000 and €340,000. It is a rough estimate. In financial year 2020 turnover was €241,396.
Is MEDISOINS BRUXELLES profitable?
In financial year 2025, MEDISOINS BRUXELLES made a profit of €21,732.
Where can I find the annual accounts of MEDISOINS BRUXELLES?
MEDISOINS BRUXELLES filed 15 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of MEDISOINS BRUXELLES due?
MEDISOINS BRUXELLES must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.